Skip to main content

Table 2 Baseline characteristics by exposure level (no exposure, exposed to ACT, exposed to quinine), ASAP cohort, 2015

From: First trimester use of artemisinin-based combination therapy and the risk of low birth weight and small for gestational age

CharacteristicNo anti-malarial use in first trimesterConfirmed ACT use in first trimesterConfirmed quinine use in first trimesterAll pregnancies
N (%)N (%)N (%)N (%)
Total1797 (100)92 (100)26 (100)1915 (100)
Country
 Burkina Faso603 (33.6)31 (33.7)22 (84.6)656 (34.3)
 Mozambique643 (35.8)22 (23.9)4 (15.4)669 (34.9)
 Kenya551 (30.7)39 (42.4)0 (0.0)590 (30.8)
Age at recruitment (years)
 Range12.4–49.015.0–45.017.0–36.012.4–49.0
 Mean (SD)25.7 (6.55)25.6 (6.63)24.7 (6.04)25.6 (6.54)
 < 20394 (21.9)17 (18.5)7 (26.9)418 (21.8)
 20–24465 (25.9)30 (32.6)7 (26.9)502 (26.2)
 25–29444 (24.7)19 (20.7)7 (26.9)470 (24.5)
 30+494 (27.5)26 (28.3)5 (19.2)525 (27.4)
Gravidity
 Primigravida378 (21.0)23 (25.0)8 (30.8)409 (21.4)
 1–3 pregnancies943 (52.5)45 (48.9)11 (42.3)999 (52.2)
 4 or more pregnancies473 (26.3)24 (26.1)7 (26.9)504 (26.3)
 Missing3 (0.2)0 (0.0)0 (0.0)3 (0.2)
Marital status
 Single354 (19.7)20 (21.7)0 (0.0)374 (19.5)
 Married or cohabiting1442 (80.2)72 (78.3)26 (100.0)1540 (80.4)
 Missing1 (0.1)0 (0.0)0 (0.0)1 (0.1)
Education
 Primary not completed348 (19.4)16 (17.4)0 (0.0)364 (19.0)
 Primary completed1176 (65.4)62 (67.4)24 (92.3)1262 (65.9)
 Secondary completed271 (15.1)14 (15.2)2 (7.7)287 (15.0)
 Missing2 (0.1)0 (0.0)0 (0.0)2 (0.1)
HIV status
 Negative1427 (79.4)70 (76.1)23 (88.5)1520 (79.4)
 Positive279 (15.5)13 (14.1)1 (3.8)293 (15.3)
 Missing91 (5.1)9 (9.8)2 (7.7)102 (5.3)
Gestational age at recruitment (weeks)
 Mean (SD)21.3 (7.39)18.8 (8.72)16.8 (5.56)21.2 (7.88)
Gestational age at delivery (weeks)
 Mean (SD)38.9 (1.80)39.0 (1.77)38.8 (1.65)38.9 (1.79)
  1. SD standard deviation